[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
May 16, 2001

Vitamin E Supplementation in Healthy Persons—Reply

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;285(19):2449-2450. doi:10.1001/jama.285.19.2449

In Reply: In response to Dr Dixon, we designed the study in 8-week dosing intervals because these were sufficient to attain steady-state suppression of elevated urinary isoprostanes in patients with syndromes of oxidant stress and in animal models of disease.1,2 Steady-state circulating levels of vitamin E are attained much earlier than these pharmacodynamic responses. Clearly an impact on a chronic disease process in which lipid peroxidation may play a role, such as human atherosclerosis, may require longer periods of follow-up to assess clinical end points, even using contemporary approaches to measurement of plaque progression, such as electron beam computed tomography or magnetic resonance imaging.

First Page Preview View Large
First page PDF preview
First page PDF preview
×